Factors associated with choice of first biologic among children with juvenile idiopathic arthritis: a combined analysis from two UK paediatric biologic registers
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1546-0096
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Factors associated with choice of first biologic among children with juvenile idiopathic arthritis: a combined analysis from two UK paediatric biologic registers ; volume:12 ; number:1 ; day:17 ; month:9 ; year:2014 ; pages:1-2 ; date:9.2014
Pediatric rheumatology ; 12, Heft 1 (17.9.2014), 1-2, 9.2014
- Urheber
-
Davies, Rebecca
Kearsley-Fleet, Lianne
Baildam, Eileen
Beresford, Michael W.
Foster, Helen
Southwood, Taunton R.
Thomson, Wendey
Hyrich, Kimme L.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1546-0096-12-S1-P190
- URN
-
urn:nbn:de:101:1-2021082619093520146380
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Davies, Rebecca
- Kearsley-Fleet, Lianne
- Baildam, Eileen
- Beresford, Michael W.
- Foster, Helen
- Southwood, Taunton R.
- Thomson, Wendey
- Hyrich, Kimme L.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Biologic switching patterns among children with non-systemic juvenile idiopathic arthritis
Biologic agents in juvenile spondyloarthropathies
The efficacy and safety profile of biologic therapy with etanercept in juvenile idiopathic arthritis
Biologic system evaluation with ultrasound
Disease activity and damage in juvenile idiopathic arthritis: methotrexate era versus biologic era
Treatment of Atopic Dermatitis with Biologic Drugs
Biologic monotherapy in the biologic naïve patient with rheumatoid arthritis (RA): results from an observational study
Biologic basis of pigmentation
Clinical phenotypes and biologic treatment use in juvenile dermatomyositis-associated calcinosis
Biologic therapies in polyarticular juvenile idiopathic arthritis. Comparison of long‐term safety data from the German biker registry
Prescribed but not approved: biologic agents used without approval in juvenile idiopathic arthritis in Switzerland, France and Belgium
Infliximab in chronic non-infectious paediatric uveitis refractory to previous biologic therapy
Biologic switching patterns among children with non-systemic juvenile idiopathic arthritis
Biologic agents in juvenile spondyloarthropathies
The efficacy and safety profile of biologic therapy with etanercept in juvenile idiopathic arthritis
Biologic system evaluation with ultrasound
Disease activity and damage in juvenile idiopathic arthritis: methotrexate era versus biologic era
Treatment of Atopic Dermatitis with Biologic Drugs
Biologic monotherapy in the biologic naïve patient with rheumatoid arthritis (RA): results from an observational study
Biologic basis of pigmentation
Clinical phenotypes and biologic treatment use in juvenile dermatomyositis-associated calcinosis
Biologic therapies in polyarticular juvenile idiopathic arthritis. Comparison of long‐term safety data from the German biker registry
Prescribed but not approved: biologic agents used without approval in juvenile idiopathic arthritis in Switzerland, France and Belgium
Infliximab in chronic non-infectious paediatric uveitis refractory to previous biologic therapy
Biologic switching patterns among children with non-systemic juvenile idiopathic arthritis
Biologic agents in juvenile spondyloarthropathies
The efficacy and safety profile of biologic therapy with etanercept in juvenile idiopathic arthritis
Biologic system evaluation with ultrasound
Disease activity and damage in juvenile idiopathic arthritis: methotrexate era versus biologic era
Treatment of Atopic Dermatitis with Biologic Drugs
Biologic monotherapy in the biologic naïve patient with rheumatoid arthritis (RA): results from an observational study
Biologic basis of pigmentation
Clinical phenotypes and biologic treatment use in juvenile dermatomyositis-associated calcinosis
Biologic therapies in polyarticular juvenile idiopathic arthritis. Comparison of long‐term safety data from the German biker registry
Prescribed but not approved: biologic agents used without approval in juvenile idiopathic arthritis in Switzerland, France and Belgium